Popular Articles From: Arrayit Corporation Subsidiary Avant Diagnostics, Inc. Acquired by American Liberty Petroleum Corporation to BlackRock Investment Institute’s 2015 Investment Outlook: DEALING WITH DIVERGENCE


2014/12/31
SUNNYVALE, Calif., Dec.
Sign-up for Arrayit Corporation Subsidiary Avant Diagnostics, Inc. Acquired by American Liberty Petroleum Corporation investment picks
2014/12/15
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration for ARC-520, it’s drug candidate for the treatment of chronic hepatitis B virus (HBV) infection.
Sign-up for Arrowhead Files IND for RNAi Therapeutic ARC-520 to Begin Phase 2b Multiple-Dose Studies in Chronic Hepatitis B Patients investment picks
2014/12/17
CBL & Associates Properties, Inc. (NYSE: CBL) today announced a new DICK’S Sporting Goods and ULTA Beauty are coming to Janesville Mall in Janesville, Wisconsin.
Sign-up for CBL Announces DICK’s Sporting Goods and ULTA Beauty to Join Janesville Mall as Part of Anchor Redevelopment investment picks
2015/1/14
AstraZeneca (NYSE:AZN) today announced that the PEGASUS-TIMI 54 study, a large scale outcomes trial involving over 21,000 patients, successfully met its primary efficacy endpoint.
Sign-up for PEGASUS-TIMI 54 Study of BRILINTA® Meets Primary Endpoint in Both 60mg and 90mg Doses investment picks
2014/12/24
EAST AURORA, N.Y., Dec.
Sign-up for Astronics to Acquire Armstrong Aerospace investment picks
2015/1/20
TORTOLA, UNITED KINGDOM --
Sign-up for Atlas Mara Co-Nvest Limited Directorate Change investment picks
2014/12/23
PITTSBURGH , Dec.
Sign-up for Atlas Resource Partners, L.P. Announces Monthly Distribution for November 2014 investment picks
2014/12/23
PITTSBURGH , Dec.
Sign-up for Atlas Resource Partners, L.P. Announces Initial Class D Preferred Unit Distribution investment picks
2014/12/19
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1166103&ProfileId=051205&sourceType=1 SEATTLE, WA --
Sign-up for Atossa Genetics Inc. Provides Update on Pharmacogenetics Testing Now Offered by The National Reference Laboratory for Breast Health, Inc. investment picks
2014/12/9
--Award-Winning Filmmakers Capture Untold Story of Little-Known Neurologic Condition That Affects Nearly 2 Million Americans--
Sign-up for Through Laughter and Tears Comes First-Ever Documentary about Life with PseudoBulbar Affect (PBA) investment picks
2014/12/2
Avnet Technology Solutions , the global IT solutions distribution leader and an operating group of Avnet, Inc. (NYSE: AVT ), will be the first distributor in the U.S. to offer solution provider partners HP ConvergedSystem 700 powered by HP OneView , a comprehensive, innovative solution that delivers a software-defined environment to help customers embrace an open hybrid cloud model with best-of-breed converged infrastructure.
Sign-up for Avnet Technology Solutions Selected to Bring HP ConvergedSystem 700 to Market in the U.S. investment picks
2015/1/12
Axalta Coating Systems (NYSE: AXTA), a leading global supplier of liquid and powder coatings, and Shanghai Kinlita Chemical (SZSE: 300225), a renowned player in China’s industrial coatings industry, have today signed an agreement to form a joint venture in China.
Sign-up for Axalta and Kinlita Sign Joint Venture Agreement to Provide Coatings to China’s Commercial Truck Market investment picks
2014/12/11
Axalta Coating Systems (NYSE:AXTA), a leading global supplier of liquid and powder coatings, launches its new generation C6 electrical steel varnish - Voltatex ® 1262.
Sign-up for Axalta Launches New Generation C6 Formaldehyde-Free Electrical Steel Varnish investment picks
2014/12/15
HOUSTON , Dec.
Sign-up for Baker Hughes Announces Fourth Quarter 2014 Conference Call investment picks
2015/1/7
http://www.ccnmatthews.com/logos/20060817-barrick.jpg TORONTO, ONTARIO --
Sign-up for Barrick Gold Corporation Fourth Quarter 2014 Results Release, Conference Call and Webcast investment picks
2014/12/10
Baxter International Inc. (NYSE:BAX) announced the filing of an initial Form 10 Registration Statement with the U.S. Securities and Exchange Commission (SEC) in connection with the company’s previously announced plan to spin off its biopharmaceutical business.
Sign-up for Baxter Announces Filing of Form 10 Registration Statement in Connection with Planned Spin off of Biopharmaceuticals Business investment picks
2014/12/15
http://www.ccnmatthews.com/logos/20110114-baytex_200.jpg CALGARY, ALBERTA --
Sign-up for Baytex Confirms Monthly Dividend for December at $0.10 Per Share investment picks
2015/1/6
Tallgrass Pony Express Pipeline, LLC (Pony Express), Belle Fourche Pipeline Company (BFPL) and Bridger Pipeline LLC (Bridger) announced today a joint tariff open season soliciting shipper commitments for crude oil transportation service under a joint tariff from receipt points on the Belle Fourche and Bridger systems in Montana, Wyoming and N.
Sign-up for Tallgrass Pony Express Pipeline, Belle Fourche Pipeline Company and Bridger Pipeline LLC Announce Joint Tariff Open Season investment picks
2015/1/14
Multi GRAMMY® Award Winner Vince Gill, Frontier Communications, DISH Network and CoBank will announce a new partnership as part of the America’s Best Communities (ABC) campaign promoting investment to revitalize small towns and cities.
Sign-up for Country Music’s Vince Gill to Join Frontier Communications, DISH Network and CoBank to Announce Investment in Small-Town America investment picks
2015/1/8
Biogen Idec (NASDAQ: BIIB) today announced top-line results from the Phase 2 acute optic neuritis (AON) RENEW trial in which treatment with anti-LINGO-1 showed evidence of biological repair of the visual system.
Sign-up for Biogen Idec Reports Positive Top-Line Results from Phase 2 Anti-LINGO-1 Trial in People with Acute Optic Neuritis investment picks
2014/12/2
By Russ Britt, MarketWatch Stock leaps as new treatment leap past a testing step LOS ANGELES (MarketWatch) -- Plans by Biogen Idec Inc. to move directly from Phase I to Phase III testing on an Alzheimer's treatment boosted shares of the company nearly 7% early Tuesday.
Sign-up for Biogen Alzheimer's drug skips to Phase 3 testing investment picks
2015/1/5
Proprietary, Clinical Grade HypoThermosol® and CryoStor® Extending Shelf Life and Improving Survival & Function of CAR-T Cells, Dendritic Cells, Etc.
Sign-up for BioLife Solutions Biopreservation Media Products Embedded in 175 Cellular Immunotherapy & Other Regenerative Medicine Clinical Trials investment picks
2015/1/6
BioLineRx (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that its Chief Executive Officer, Kinneret Savitsky, Ph.D., and its Chief Financial and Operating Officer, Philip Serlin, will be presenting at the Biotech Showcase 2015 Conference being held at the Parc 55 Wyndham Union Square Hotel in San Francisco, CA.
Sign-up for BioLineRx to Present at Biotech Showcase 2015 Conference in San Francisco investment picks
2014/12/1
MONTREAL , Dec.
Sign-up for Telesta Therapeutics Announces Key Clinical & Corporate Updates investment picks
2014/12/9
Formulated to Help Alleviate Symptoms Associated with Fibrocystic Breast Condition for the Estimated 50 Percent of Women Aged 15 to 49 Who Suffer from Monthly Breast Discomfort MENLO PARK, Calif.
Sign-up for Introducing Violet™ Iodine, New Once-Daily, Non-Prescription Pill For Relief Of Premenstrual Breast Discomfort* investment picks
2014/12/9
The return of volatility—as valuations and investor complacency remain elevated—will make it vital for investors to consider hedging against downside risk and cut back on "me too" investments in the new year, according to the BlackRock (NYSE: BLK) Investment Institute's (“BII”) 2015 Investment Outlook.
Sign-up for BlackRock Investment Institute’s 2015 Investment Outlook: DEALING WITH DIVERGENCE investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Popular Articles From: Arrayit Corporation Subsidiary Avant Diagnostics, Inc. Acquired by American Liberty Petroleum Corporation to BlackRock Investment Institute’s 2015 Investment Outlook: DEALING WITH DIVERGENCE
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent